These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 26790665)
1. Factors that influence the pharmacokinetics of lamotrigine in Japanese patients with epilepsy. Inoue K; Yamamoto Y; Suzuki E; Takahashi T; Umemura A; Takahashi Y; Imai K; Inoue Y; Hirai K; Tsuji D; Itoh K Eur J Clin Pharmacol; 2016 May; 72(5):555-62. PubMed ID: 26790665 [TBL] [Abstract][Full Text] [Related]
2. Influence of valproic acid concentration and polymorphism of UGT1A4*3, UGT2B7 -161C > T and UGT2B7*2 on serum concentration of lamotrigine in Chinese epileptic children. Liu L; Zhao L; Wang Q; Qiu F; Wu X; Ma Y Eur J Clin Pharmacol; 2015 Nov; 71(11):1341-7. PubMed ID: 26303110 [TBL] [Abstract][Full Text] [Related]
3. Population pharmacokinetics of lamotrigine co-administered with valproic acid in Chinese epileptic children using nonlinear mixed effects modeling. Xu S; Liu L; Chen Y; Liu M; Lu T; Wang H; Liu S; Zhao M; Zhao L Eur J Clin Pharmacol; 2018 May; 74(5):583-591. PubMed ID: 29340733 [TBL] [Abstract][Full Text] [Related]
4. Effects of UGT2B7 Genetic Polymorphisms on Serum Concentrations of Valproic Acid in Chinese Children With Epilepsy Comedicated With Lamotrigine. Wang Q; Zhao L; Liang M; Dong Y; Yun W; Qiu F; Meng H; Guo Y Ther Drug Monit; 2016 Jun; 38(3):343-9. PubMed ID: 26717295 [TBL] [Abstract][Full Text] [Related]
5. Effects of UGT1A4 genetic polymorphisms on serum lamotrigine concentrations in Chinese children with epilepsy. Wang Q; Liang M; Dong Y; Yun W; Qiu F; Zhao L; Guo Y Drug Metab Pharmacokinet; 2015 Jun; 30(3):209-13. PubMed ID: 25922177 [TBL] [Abstract][Full Text] [Related]
6. Correlation of the UGT1A4 gene polymorphism with serum concentration and therapeutic efficacy of lamotrigine in Han Chinese of Northern China. Chang Y; Yang LY; Zhang MC; Liu SY Eur J Clin Pharmacol; 2014 Aug; 70(8):941-6. PubMed ID: 24820767 [TBL] [Abstract][Full Text] [Related]
7. Association of UGT2B7 and UGT1A4 Polymorphisms with Serum Concentration of Antiepileptic Drugs in Children. Du Z; Jiao Y; Shi L Med Sci Monit; 2016 Oct; 22():4107-4113. PubMed ID: 27795544 [TBL] [Abstract][Full Text] [Related]
8. The relationship between UGT1A4 polymorphism and serum concentration of lamotrigine in patients with epilepsy. Gulcebi MI; Ozkaynakcı A; Goren MZ; Aker RG; Ozkara C; Onat FY Epilepsy Res; 2011 Jun; 95(1-2):1-8. PubMed ID: 21601426 [TBL] [Abstract][Full Text] [Related]
9. Influence of the UGT2B7 -161C>T polymorphism on the population pharmacokinetics of lamotrigine in Thai patients. Singkham N; Towanabut S; Lertkachatarn S; Punyawudho B Eur J Clin Pharmacol; 2013 Jun; 69(6):1285-91. PubMed ID: 23263737 [TBL] [Abstract][Full Text] [Related]
10. Influence of concomitant antiepileptic drugs on plasma lamotrigine concentration in adult Japanese epilepsy patients. Yamamoto Y; Inoue Y; Matsuda K; Takahashi Y; Kagawa Y Biol Pharm Bull; 2012; 35(4):487-93. PubMed ID: 22466551 [TBL] [Abstract][Full Text] [Related]
11. Impact of UGT1A4 and UGT2B7 polymorphisms on lamotrigine plasma concentration in patients with bipolar disorder. Zhao T; Zhang HL; Feng J; Cui L; Sun L; Li HJ; Yu LH Pharmacogenet Genomics; 2024 Oct; 34(8):261-267. PubMed ID: 39171428 [TBL] [Abstract][Full Text] [Related]
13. The effects of co-medications on lamotrigine clearance in Japanese children with epilepsy. Takeuchi T; Natsume J; Kidokoro H; Ishihara N; Yamamoto H; Azuma Y; Ito Y; Kurahashi N; Tsuji T; Suzuki M; Itomi K; Yamada K; Kurahashi H; Abe S; Okumura A; Maruyama K; Negoro T; Watanabe K; Kojima S Brain Dev; 2016 Sep; 38(8):723-30. PubMed ID: 27033151 [TBL] [Abstract][Full Text] [Related]
14. Effect of UGT1A4, UGT2B7, UGT2B15, UGT2B17 and ABC1B polymorphisms on lamotrigine metabolism in Danish patients. Petrenaite V; Öhman I; Jantzen FPT; Ekström L Epilepsy Res; 2022 May; 182():106897. PubMed ID: 35303539 [TBL] [Abstract][Full Text] [Related]
15. UGT2B7_-161C>T polymorphism is associated with lamotrigine concentration-to-dose ratio in a multivariate study. Blanca Sánchez M; Herranz JL; Leno C; Arteaga R; Oterino A; Valdizán EM; Nicolas JM; Adín J; Shushtarian M; Armijo JA Ther Drug Monit; 2010 Apr; 32(2):177-84. PubMed ID: 20216122 [TBL] [Abstract][Full Text] [Related]
16. Influence of uridine diphosphate glucuronosyltransferase 2B7 -161C>T polymorphism on the concentration of valproic acid in pediatric epilepsy patients. Inoue K; Suzuki E; Yazawa R; Yamamoto Y; Takahashi T; Takahashi Y; Imai K; Koyama S; Inoue Y; Tsuji D; Hayashi H; Itoh K Ther Drug Monit; 2014 Jun; 36(3):406-9. PubMed ID: 24365988 [TBL] [Abstract][Full Text] [Related]
17. No association between non-bullous skin reactions from lamotrigine and heterozygosity of UGT1A4 genetic variants *2(P24T) or *3(L48V) in Norwegian patients. Shirzadi M; Reimers A; Helde G; Sjursen W; Brodtkorb E Seizure; 2017 Feb; 45():169-171. PubMed ID: 28068583 [TBL] [Abstract][Full Text] [Related]
18. The influence of concomitant antiepileptic drugs on lamotrigine serum concentrations in Northwest Chinese Han population with epilepsy. Han X; Huang J; Lv J; Ma L; Peng L; Wang J; Nie X; Xia L; Zan X PLoS One; 2019; 14(1):e0210600. PubMed ID: 30645607 [TBL] [Abstract][Full Text] [Related]
19. [Relationship between UGT1A4 142T>G polymorphism and serum concentration of lamotrigine in Chinese epileptic patients: a meta-analysis]. Li Z; Wang Y Zhonghua Yi Xue Za Zhi; 2018 Nov; 98(41):3365-3370. PubMed ID: 30440130 [No Abstract] [Full Text] [Related]
20. Specific OCT1 and ABCG2 polymorphisms are associated with Lamotrigine concentrations in Chinese patients with epilepsy. Shen CH; Zhang YX; Lu RY; Jin B; Wang S; Liu ZR; Tang YL; Ding MP Epilepsy Res; 2016 Nov; 127():186-190. PubMed ID: 27610747 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]